Further studies are required to explore the underlying mechanisms leading to this increased expression and function of Glut1 and to ascertain whether this may be exploited to enhance CNS delivery of therapeutics in ALS, for example by conjugating glucose-like entities to assist trafficking across the BBB [39]. Here, SLC2A1 is linked to amyotrophic lateral sclerosis.